Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 14 Oct 2026 09:00 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: SoftOx Solutions AS exercises on the financing facility with Long State Investments Limited | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 08 Oct 2026 14:14 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: SoftOx reports more than 99.99999 percent reduction of plague bacteria in laboratory testing of SIS | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 29 Sep 2026 09:19 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: SoftOx attracts renowned inhaled antimicrobial expert Dr. Bruce Montgomery to lead Clinical Advisory Board ahead of Phase 2b | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 Sep 2026 13:09 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Analyst Group Initiates Coverage of SoftOx Solutions and Comments on the H1 2026 Report | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 Sep 2026 08:00 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Half Year Report 2026 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 Aug 2026 08:18 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: New Share Capital | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 11 Aug 2026 10:35 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: FIRST PATIENT DOSED IN SIS-03 PROOF-OF-CONCEPT PATIENT TRIAL | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 07 Jul 2026 15:24 CEST |
SOFTOX SOLUTIONS | SoftOx Solution AS: Mandatory notification of trade by primary insider related to the Private Placement and Debt Conversion. | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 06 Jul 2026 20:05 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Private Placement Resolved | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 26 Jun 2026 09:00 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: POSITIVE TOPLINE SAFETY DATA FROM SIS-03 DOSE-ESCALATION PHASE | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 24 Jun 2026 11:47 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Minutes from the General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 24 Jun 2026 08:00 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: First Quarter Report 2026 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 18 Jun 2026 13:54 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: New Share Capital | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 09 Jun 2026 09:48 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Notice of General Assembly | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 09 Jun 2026 08:00 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: SoftOx Solutions AS exercises on the financing facility with Long State Investments Limited | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 08 Jun 2026 09:00 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: SIS-03 DOSE-ESCALATION PHASE COMPLETED AND INITIATION OF PROOF-OF-CONCEPT PHASE | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 05 Jun 2026 09:44 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: FIRST PARTICIPANT ENROLLED IN BIODEFENCE-FOCUSED SIS-02 PHASE 1 CLINICAL STUDY | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 May 2026 08:00 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Annual Report 2025 | 20103010 Biotechnology | Annual financial and audit Reports |
| 21 Apr 2026 13:44 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: New Share Capital | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 13 Apr 2026 08:31 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: SoftOx Solutions AS exercises on the financing facility with Long State Investments Limited | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 25 Mar 2026 08:00 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Fourth Quarter Report 2025 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 24 Mar 2026 21:36 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: New Share Capital | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 11 Mar 2026 10:00 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: SoftOx Solutions AS exercises on the financing facility with Long State Investments Limited | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Mar 2026 08:24 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: First Subject Dosed in Combined Phase 2a Dose-Escalation and Proof-of-Concept Trial (SIS-03) | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 25 Feb 2026 08:00 CET |
SOFTOX SOLUTIONS | SoftOx Defense Solutions AS: HPRA Approves SIS-02 Phase 1 Trial, Strengthening Dual-Use and Preparedness Strategy | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Feb 2026 12:43 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: New Share Capital | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 Jan 2026 14:36 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: SoftOx Solutions AS exercises on the financing facility with Long State Investments Limited | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 29 Dec 2025 09:33 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Danish Medicines Agency Approves Phase 2a Trial for SoftOx Inhalation Solution | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 18 Dec 2025 17:05 CET |
SOFTOX SOLUTIONS | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 15 Dec 2025 10:23 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Minutes from the Extraordinary General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 05 Dec 2025 18:11 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: New Share Capital | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 Nov 2025 14:32 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Notice of Extraordinary General Assembly | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 Nov 2025 14:31 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: SoftOx Solutions AS exercises on the financing facility with Long State Investments Limited | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 26 Nov 2025 08:00 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Third Quarter Report 2025 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 14 Nov 2025 08:35 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: GMP Drug Substance Successfully Manufactured – Key Milestone for CF and EDF Clinical Programs | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 16 Oct 2025 12:26 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: SoftOx submits Phase 1 Clinical Trial Application under the European Defence Fund (EDF) Program | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 13 Oct 2025 08:11 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: New Share Capital | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 07 Oct 2025 21:17 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Private Placement resolved | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Oct 2025 15:23 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: New Share Capital | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 01 Oct 2025 14:35 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Clinical Trial Application for Dose Escalation / Cystic Fibrosis Phase 2a – Important Milestone Achieved | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 25 Sep 2025 17:51 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Clarification on Placement Commission | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 25 Sep 2025 15:08 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Private Placements resolved | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 Sep 2025 09:07 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: SoftOx builds momentum: CF trial strategy reinforced by HOCl stability breakthrough | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 Sep 2025 08:00 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: SoftOx builds momentum: CF trial strategy reinforced by HOCl stability breakthrough | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 17 Sep 2025 08:00 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Second Quarter/Half-Year Report 2025 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 11 Sep 2025 15:59 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Softox Solutions AS exercises on the financing facility with Long State Investments Limited | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 08 Sep 2025 12:07 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Presentation Deck and link to today's Investor Update | 20103010 Biotechnology | Non-regulatory press releases |
| 08 Sep 2025 08:00 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Reminder - Investor Update in connection with the Refinement of the Clinical Focus into Chronic Lung Disease Treatment | 20103010 Biotechnology | Non-regulatory press releases |
| 03 Sep 2025 12:39 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Investor Update in connection with the Refinement of the Clinical Focus into Chronic Lung Disease Treatment | 20103010 Biotechnology | Non-regulatory press releases |
| 02 Sep 2025 08:59 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Refines Clinical Focus and Advances Into Chronic Lung Disease Treatments | 20103010 Biotechnology | Inside information |